On the occasion of the 17th session of the Convention on Biological Diversity Conference of the Parties (COP17), Guilherme Cintra, Director, Innovation Policy, IFPMA said: “The pharmaceutical industry ...
On 29 October 2026, IFPMA submitted a statement on a strategy and action plan for tackling non-communicable diseases and advancing well being through health promotion in the WHO European Region ...
On 29 October 2026, IFPMA delivered a statement on the roadmap for action on artificial intelligence in health in the WHO European Region 2026–2033 at the 76th WHO Regional Committee for Europe in ...
On 28 October 2026, IFPMA submitted a statement on the global health architecture at the 76th WHO Regional Committee for Europe in Copenhagen. IFPMA welcomes the discussion on global health ...
On 27 October 2026, IFPMA and EFPIA delivered a joint statement during the general debate of the 76th WHO Regional Committee for Europe in Copenhagen. The European region is currently facing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results